A Virtual Reality View - Optimizing Immuno-Oncology Therapy Through the Management of Immune-Related Adverse Events: The Role of the Emergency Physician

A Virtual Reality View - Optimizing Immuno-Oncology Therapy Through the Management of Immune-Related Adverse Events: The Role of the Emergency Physician is organized by Med Learning Group.

Release Date: August 20, 2018
Expiration Date: August 20, 2019

Target Audience:
This activity is intended to meet the educational needs of Emergency Department physicians and other Emergency Room healthcare professionals working as part of the multidisciplinary care team.

Credits:
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit: 1.0 ANCC Contact Hour(s)

Program Overview:
This case-based enduring activity will cover the long-term treatment and management of patients with adverse events related to cancer immunotherapy.

Learning Objectives:
After completing the CME activity, learners should be better able to:
• Discuss tumor immunosurveillance and immune escape in the pathophysiology of adult malignancies;
• Review the clinical trial data for approved immune checkpoint-inhibitors, with a focus on the treated malignancies and their associated immune-related adverse events (irAEs);
• Describe the diagnosis of irAEs associated with immunotherapies and current recommendations for their management and monitoring;
• Examine the continuum of oncology care provided in the emergency room setting through the identification and management of irAEs.